A large body of research has shown the presence of a complex pathway of communications between the gut and the brain. It is now recognized that, through this pathway, the microbiota can influence brain homeostasis and plasticity under normal and pathological conditions. This review aims at providing an overview of preclinical and clinical pieces of evidence supporting the possible role of gutbrain axis modulation in physiological aging, in a neurodevelopmental disorder, the autism spectrum disorders and in a substance abuse disorder, the alcohol addiction. Since the normalization of gut flora can prevent changes in the behavior, we postulate that the gut-brain axis might represent a possible target for pharmacological and dietary strategies aimed at improving not only intestinal but also mental health. The present review also reports some regulatory considerations regarding the use of probiotics, illustrating the most debated issues about the possibility of considering probiotics not only as a food supplement but also as a "full" medicinal product.
Petrella, C., Farioli-Vecchioli, S., Cisale, G.y., Strimpakos, G., Borg, J.j., Ceccanti, M., et al. (2021). A healthy gut for a healthy brain: preclinical, clinical and regulatory aspects. CURRENT NEUROPHARMACOLOGY, 19(5), 610-628 [10.2174/1570159X18666200730111528].
A healthy gut for a healthy brain: preclinical, clinical and regulatory aspects
Nisticò, Robert
2021-07-30
Abstract
A large body of research has shown the presence of a complex pathway of communications between the gut and the brain. It is now recognized that, through this pathway, the microbiota can influence brain homeostasis and plasticity under normal and pathological conditions. This review aims at providing an overview of preclinical and clinical pieces of evidence supporting the possible role of gutbrain axis modulation in physiological aging, in a neurodevelopmental disorder, the autism spectrum disorders and in a substance abuse disorder, the alcohol addiction. Since the normalization of gut flora can prevent changes in the behavior, we postulate that the gut-brain axis might represent a possible target for pharmacological and dietary strategies aimed at improving not only intestinal but also mental health. The present review also reports some regulatory considerations regarding the use of probiotics, illustrating the most debated issues about the possibility of considering probiotics not only as a food supplement but also as a "full" medicinal product.File | Dimensione | Formato | |
---|---|---|---|
CN-2020-0149.R revised.pdf
solo utenti autorizzati
Descrizione: A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects
Tipologia:
Documento in Pre-print
Licenza:
Copyright dell'editore
Dimensione
503.76 kB
Formato
Adobe PDF
|
503.76 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.